Pregled bibliografske jedinice broj: 1088366
The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease
The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease // Frontiers in Molecular Neuroscience, 13 (2020), 572308, 19 doi:10.3389/fnmol.2020.572308 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1088366 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease
Autori
Zubčić, Klara ; Hof, Patrik ; Šimić, Goran ; Jazvinšćak Jembrek, Maja
Izvornik
Frontiers in Molecular Neuroscience (1662-5099) 13
(2020);
572308, 19
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
copper ; tau ; aggregation ; oxidative stress ; Alzheimer’s disease
Sažetak
All tauopathies, including Alzheimer’s disease (AD), are characterized by the intracellular accumulation of abnormal forms of tau protein in neurons and glial cells, which negatively affect microtubule stability. Under physiological conditions, tubulin-associated unit (Tau) protein is intrinsically disordered, almost without secondary structure, and is not prone to aggregation. In AD, it assembles, and forms paired helical filaments (PHFs) that further build-up neurofibrillary tangles (NFTs). Aggregates are composed of hyperphosphorylated tau protein that is more prone to aggregation. The pathology of AD is also linked to disturbed copper homeostasis, which promotes oxidative stress (OS). Copper imbalance is widely observed in AD patients. Deregulated copper ions may initiate and exacerbate tau hyperphosphorylation and formation of b-sheet-rich tau fibrils that ultimately contribute to synaptic failure, neuronal death, and cognitive decline observed in AD patients. The present review summarizes factors affecting the process of tau aggregation, conformational changes of small peptide sequences in the microtubulebinding domain required for these motifs to act as seeding sites in aggregation, and the role of copper in OS induction, tau hyperphosphorylation and tau assembly. A better understanding of the various factors that affect tau aggregation under OS conditions may reveal new targets and novel pharmacological approaches for the therapy of AD.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Hrvatsko katoličko sveučilište, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus